Figure 2 : CNS Emryonal tumor. IHC. Synaptphysin. Tumor celles
express neuronal marquer. HEx20
Our patient underwent a thoracic, abdominal, and pelvic CT scan that
showed pulmonary embolism with no secondary localizations of the tumor,
a cerebral residual tumor of 4 cm, and a bone scan that was normal.
Seeing the recurrence of the patient’s symptoms after two months, an MRI
was performed that showed tumor recurrence with edema and hemorrhagic
areas and meningeal carcinomatosis. Another surgery was performed with
total resection, with cerebrospinal fluid analysis revealing no
malignant cells. A second recurrence of intracranial hypertension
symptoms led to the discovery of areas of meningeal enhancement
involving the supratentorial region of the brain.
The patient began to receive two of the planned eight cycles of
platinum- and alkylator-based chemotherapy. This initially consisted of
cisplatin, vincristine, and cyclophosphamide (VIP), with improvement in
the patient’s presenting symptoms.